PMID- 37330034 OWN - NLM STAT- MEDLINE DCOM- 20230807 LR - 20230808 IS - 1879-3185 (Electronic) IS - 0300-483X (Linking) VI - 494 DP - 2023 Aug 1 TI - BDE209-promoted Dio2 degradation in H4 glioma cells through the autophagy pathway, resulting in hypothyroidism and leading to neurotoxicity. PG - 153581 LID - S0300-483X(23)00167-1 [pii] LID - 10.1016/j.tox.2023.153581 [doi] AB - Decabromodiphenyl ether (BDE209), the homologue with the highest number of brominates in polybrominated diphenyl ethers (PBDEs), is one of the most widespread environmental persistent organic pollutants (POPs) due to its mass production and extensive application in recent decades. BDE209 is neurotoxic, possibly related to its interference with the thyroid hormone (TH) system. However, the underlying molecular mechanisms of BDE209-induced TH interference and neurobehavioral disorders remains unknown. Here, we explored how BDE209 manipulated the major enzyme, human type II iodothyronine deiodinase (Dio2), that is most important in regulating local cerebral TH equilibrium by neuroglial cells, using an in vitro model of human glioma H4 cells. Clonogenic cell survival assay and LC/MS/MS analysis showed that BDE209 could induce chronic neurotoxicity by inducing TH interference. Co-IP assay, RT-qPCR and confocal assay identified that BDE209 destroyed the stability of Dio2 without affecting its expression, and promoted its binding to p62, thereby enhancing its autophagic degradation, thus causing TH metabolism disorder and neurotoxicity. Furthermore, molecular docking studies predicted that BDE209 could effectively suppress Dio2 activity by competing with tetraiodothyronine (T4). Collectively, our study demonstrates that BDE209-induced Dio2 degradation and loss of its enzymatic activity in neuroglial cells are the fundamental pathogenic basis for BDE209-mediated cerebral TH disequilibrium and neurotoxicity, providing a target of interest for further investigation using glial/neuronal cell co-culture system and in vivo models. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Liu, Min AU - Liu M AD - Department of Environmental Health and Toxicology, School of Public Health, Dalian Medical University, Dalian 116044, China; Neurology Department, Dalian University Affiliated Xinhua Hospital, Dalian 116021, China. FAU - Yu, Zhenlong AU - Yu Z AD - College of Pharmacy, Dalian Medical University, Dalian 116044, China. FAU - Yang, Fangyu AU - Yang F AD - General Hospital of Northern Theater Command (General Hospital of Shenyang Military Command), Department of Neurosurgery, Shenyang, China. FAU - Zhao, Zikuang AU - Zhao Z AD - School of Pharmacy, Hangzhou Normal University, Hangzhou 116000, China. FAU - Zhou, Meirong AU - Zhou M AD - College of Pharmacy, Dalian Medical University, Dalian 116044, China. FAU - Wang, Chao AU - Wang C AD - College of Pharmacy, Dalian Medical University, Dalian 116044, China. FAU - Zhang, Baojing AU - Zhang B AD - College of Pharmacy, Dalian Medical University, Dalian 116044, China. FAU - Liang, Guobiao AU - Liang G AD - General Hospital of Northern Theater Command (General Hospital of Shenyang Military Command), Department of Neurosurgery, Shenyang, China. Electronic address: liangguobiao6708@vip.163.com. FAU - Liu, Xiaohui AU - Liu X AD - Department of Environmental Health and Toxicology, School of Public Health, Dalian Medical University, Dalian 116044, China. FAU - Shao, Jing AU - Shao J AD - Department of Environmental Health and Toxicology, School of Public Health, Dalian Medical University, Dalian 116044, China; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine; Liaoning Medical Center for Hematopoietic Stem Cell Transplantation; Dalian Key Laboratory of Hematology; Diamond Bay Institute of Hematology; Second Hospital of Dalian Medical University, Dalian 116027, China. Electronic address: jshao@u.washington.edu. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230616 PL - Ireland TA - Toxicology JT - Toxicology JID - 0361055 RN - EC 1.11.1.8 (Iodide Peroxidase) RN - 0 (Thyroid Hormones) RN - 0 (Halogenated Diphenyl Ethers) SB - IM MH - Humans MH - Iodide Peroxidase/genetics MH - Molecular Docking Simulation MH - Tandem Mass Spectrometry MH - Thyroid Hormones MH - *Hypothyroidism MH - *Glioma MH - Autophagy MH - Halogenated Diphenyl Ethers/chemistry OTO - NOTNLM OT - Autophagy OT - Decabromodiphenyl ether (BDE209) OT - Human type II iodothyronine deiodinase (Dio2) OT - Thyroid hormone COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/06/18 01:07 MHDA- 2023/08/07 06:41 CRDT- 2023/06/17 19:15 PHST- 2023/02/20 00:00 [received] PHST- 2023/06/07 00:00 [revised] PHST- 2023/06/15 00:00 [accepted] PHST- 2023/08/07 06:41 [medline] PHST- 2023/06/18 01:07 [pubmed] PHST- 2023/06/17 19:15 [entrez] AID - S0300-483X(23)00167-1 [pii] AID - 10.1016/j.tox.2023.153581 [doi] PST - ppublish SO - Toxicology. 2023 Aug 1;494:153581. doi: 10.1016/j.tox.2023.153581. Epub 2023 Jun 16.